In a newly published interview with The Wall Street Journal on January 1, 2026, President Donald Trump disclosed that he takes 325 milligrams (mg) of aspirin daily as part of his cardiac prevention routine. The revelation has sparked widespread discussion among medical professionals and public health observers, as the dosage is nearly four times higher than the commonly recommended 81 mg low-dose aspirin typically prescribed for older adults. The disclosure has reignited debates around aspirin therapy, cardiovascular health, and the risks associated with high-dose aspirin use.
Aspirin and Heart Health: The Medical Context
Aspirin has long been used in cardiovascular disease prevention due to its blood-thinning properties, which help reduce the risk of heart attacks and strokes. For decades, low-dose aspirin therapy—usually 75 to 100 mg per day—has been the standard recommendation for patients with a history of heart disease or those at elevated cardiovascular risk. The 81 mg dose, often referred to as “baby aspirin,” is widely considered effective while minimizing adverse effects.
President Trump’s confirmation of a 325 mg daily aspirin dose places his regimen well above current preventive norms. Medical experts generally reserve such higher doses for short-term treatment of acute conditions, such as pain, inflammation, or immediately following certain cardiac events, rather than for long-term daily use.
Why the Dosage Matters
The difference between low-dose and full-dose aspirin is not merely numerical. Higher aspirin dosages significantly increase the risk of side effects, particularly gastrointestinal bleeding, ulcers, and hemorrhagic stroke. In older adults, these risks are amplified due to age-related changes in the digestive system and blood vessels.
Key considerations in aspirin dosage include:
- Low-dose aspirin (81 mg): Commonly recommended for long-term cardiac prevention in high-risk individuals
- Standard-dose aspirin (325 mg): Typically used for pain relief or short-term anti-inflammatory treatment
- Potential risks of high-dose use: Increased bleeding risk, stomach irritation, and intracranial hemorrhage
Medical guidelines in recent years have become more conservative, with many health authorities advising against routine aspirin use for primary prevention in individuals without a prior history of cardiovascular disease.
Public Disclosure and Broader Implications
As a prominent public figure, President Trump’s health disclosures often attract heightened scrutiny. His statement has prompted renewed public interest in aspirin therapy and raised concerns about self-directed medication practices. Health experts emphasize that aspirin use should always be individualized and guided by a qualified physician, taking into account personal medical history, age, and overall cardiovascular risk profile.
The discussion also highlights a broader issue in preventive medicine: the misconception that higher doses equate to greater protection. In reality, modern cardiology increasingly favors precision-based prevention strategies over one-size-fits-all approaches.
